Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma

被引:0
|
作者
Eric Smith
Helen M. Palethorpe
Andrew R. Ruszkiewicz
Suzanne Edwards
Damien A. Leach
Tim J. Underwood
Eleanor F. Need
Paul A. Drew
机构
[1] The University of Adelaide,Solid Cancer Regulation Group, Discipline of Surgery, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital
[2] SA Pathology,Gastroenterology Research Laboratory
[3] The University of Adelaide,Data Management and Analysis Centre, Royal Adelaide Hospital
[4] The University of Adelaide,Cancer Biology Group, Discipline of Surgery, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital
[5] University of Southampton,Cancer Sciences Unit, Somers Cancer Research Building, Southampton General Hospital
[6] The University of Adelaide,Breast Biology and Cancer Unit, Discipline of Surgery, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital
[7] Flinders University,School of Nursing and Midwifery
来源
关键词
Adenocarcinoma of the esophagus; Androgen receptors; FK506-binding protein 5; Steroids; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:433 / 443
页数:10
相关论文
共 50 条
  • [1] Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma
    Smith, Eric
    Palethorpe, Helen M.
    Ruszkiewicz, Andrew R.
    Edwards, Suzanne
    Leach, Damien A.
    Underwood, Tim J.
    Need, Eleanor F.
    Drew, Paul A.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (02) : 433 - 443
  • [2] FKBP5 is an androgen-responsive gene in thyroid cancer cells
    MacEwan, Melanie E.
    Wong, Ken
    Swati, Ismatun
    Xie, Suqing
    Rasul, Mohammad
    Ardacheva, Olena
    Buchsbaum, Joseph
    Shin, Edward
    Moscatello, Augustine
    Schantz, Stimson
    Tiwari, Raj K.
    Geliebter, Jan
    CANCER RESEARCH, 2013, 73 (08)
  • [3] ANDROGEN RECEPTOR-BINDING REGIONS OF AN ANDROGEN-RESPONSIVE GENE
    RUSHMERE, NK
    PARKER, MG
    DAVIES, P
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1987, 51 (03) : 259 - 265
  • [4] Androgen-Responsive Gene Database: Integrated Knowledge on Androgen-Responsive Genes
    Jiang, Mei
    Ma, Yunsheng
    Chen, Congcong
    Fu, Xuping
    Yang, Shu
    Li, Xia
    Yu, Guohua
    Mao, Yumin
    Xie, Yi
    Li, Yao
    MOLECULAR ENDOCRINOLOGY, 2009, 23 (11) : 1927 - 1933
  • [5] Androgen Receptor Pathway As a Prognostic Indicator in Esophageal Adenocarcinoma
    Smith, Eric
    Palethorpe, Helen M.
    Ruszkiewicz, Andrew
    Leach, Damien
    Need, Eleanor
    Drew, Paul
    GASTROENTEROLOGY, 2015, 148 (04) : S356 - S356
  • [6] A Competitive Inhibitor That Reduces Recruitment of Androgen Receptor to Androgen-responsive Genes
    Cherian, Milu T.
    Wilson, Elizabeth M.
    Shapiro, David J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (28) : 23368 - 23380
  • [7] Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element
    Magee, JA
    Chang, LW
    Stormo, GD
    Milbrandt, J
    ENDOCRINOLOGY, 2006, 147 (01) : 590 - 598
  • [8] Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene
    Zhang, PJ
    Zhang, JY
    Young, CYF
    Kao, PC
    Chen, WW
    Jiang, AL
    Zhang, LY
    Guo, Q
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (03): : 278 - 284
  • [9] Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs
    Werner, Ralf
    Schuett, Jenny
    Hannema, Sabine
    Roepke, Albrecht
    Wieacker, Peter
    Hiort, Olaf
    Holterhus, Paul-Martin
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 101 (01): : 1 - 10
  • [10] Peroxisome proliferator-activated receptor α is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma
    Collett, GP
    Betts, AM
    Johnson, MI
    Pulimood, AB
    Cook, S
    Neal, DE
    Robson, CN
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3241 - 3248